missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ DRAK1 Polyclonal Antibody
Description
In Western blot applications, this antibody detects a band at ~50kDa. A suggested positive control is A431 cell lysate. PA5-19926 can be used with blocking peptide PEP-0051.
STK17A (DRAK1) is a serine/threonine kinase localized in the nucleus and involved in apoptosis. Diseases associated with STK17A include Colon Squamous Cell Carcinoma. Among its related pathways are Sweet Taste Signaling. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring phosphorus-containing groups and protein tyrosine kinase activity. An important paralog of this gene is STK17B.
Specifications
Specifications
| Antigen | DRAK1 |
| Applications | Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.02% sodium azide |
| Gene | STK17A |
| Gene Accession No. | Q9UEE5 |
| Gene Alias | DAP kinase-related apoptosis-inducing protein kinase 1; death-associated protein kinase-related 1; DRAK1; serine/threonine kinase 17a; serine/threonine kinase 17a (apoptosis-inducing); serine/threonine-protein kinase 17A; STK17A |
| Gene Symbols | STK17A |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?